RECENT NEWS
FierceBiotech  May 29  Comment 
After posting a trio of Phase III victories, Amgen is plotting to submit the kidney dialysis drug AMG 416 for FDA review this year, charging forward with a successor to its own Sensipar.
newratings.com  May 29  Comment 
DEERFIELD (dpa-AFX) - Baxter International Inc. (BAX) reported data which includes the perceptions of more than 500 healthcare providers and patients regarding the benefits associated with advanced automated peritoneal dialysis (APD) cyclers with...
MedPage Today  May 1  Comment 
(MedPage Today) -- AVF used less frequently in blacks, Hispanic with ESRD.
MedPage Today  Apr 29  Comment 
(MedPage Today) -- Researchers say more advance care planning is needed.
New York Times  Apr 13  Comment 
Federal lawsuits by seven plaintiffs allege a pattern of misconduct by Dr. Rex L. Mahnensmith, who was a director of the New Haven Dialysis Clinic.
MedPage Today  Mar 30  Comment 
(MedPage Today) -- Survey results suggest lack of clear guidelines leads to uncertainty.
New York Times  Mar 27  Comment 
Some older adults with advanced kidney failure are resisting the usual answer by deciding the sacrifices required by the treatment aren’t worth it.
MedPage Today  Mar 27  Comment 
(MedPage Today) -- But mortality risk for incident patients remains stubbornly high.
MedPage Today  Mar 27  Comment 
(MedPage Today) -- Two studies of phosphorus levels by race and ethnicity show opposite results.
Motley Fool  Feb 26  Comment 
The home-dialysis specialist company ended 2014 on a positive note and has high hopes for 2015.




RELATED WIKI ARTICLES
 

Companies in this industry provide dialysis services to patients with diabetes. These companies make a substantial portion of their revenue from prescribing diabetes drugs. They also heavily dependent on Medicare and Medicaid.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki